ORCL vs VRT: Which Is the Better Buy?

Side-by-side comparison of Oracle Corporation and Vertiv Holdings Co โ€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-04-18.
Oracle Corporation ยท Technology
$175.08
+24.7% upside to fair value
Grade B
VS
Vertiv Holdings Co ยท Industrials
$307.34
-11.3% upside to fair value
Grade D High Quality
QuantHub Verdict
ORCL has more upside to fair value (+24.7%). ORCL trades at a lower forward P/E (30.8x). These are model outputs โ€” not personalized investment advice. See all research โ†’
Valuation & Fundamentals
Metric ORCL VRT
Current Price $175.08 $307.34
Fair Value Estimate $218.26 $272.65
Upside to Fair Value +24.7% -11.3%
Market Cap $503.5B $117.6B
Forward P/E 30.8x 88.2x
EV / EBITDA 21.4x 55.3x
Price / Sales 7.9x 11.5x
Price / FCF -20.4x 61.2x
Revenue Growth YoY +7.0% +7.6%
Gross Margin 66.4% 34.8%
Operating Margin 30.8% 18.2%
Return on Equity 57.4% 40.3%
Dividend Yield 0% 0%
FCF Yield โ€” 1.63%
Analyst Consensus Strong Buy Strong Buy
Investment Thesis
ORCL โ€” Oracle Corporation
Oracle Corporation is a leading technology company specializing in software infrastructure, with a dominant Cloud and License Business segment generating 85.8% of its $57.4 billion revenue in fiscal 2025. The company benefits from a durable competitive moat driven by decades of leadership continuity, aggressive M&A history, and a strong position in enterprise software and cloud services. Despite โ€ฆ
VRT โ€” Vertiv Holdings Co
Vertiv Holdings Co operates as a global leader in digital critical infrastructure, providing technology products and solutions primarily for data centers, telecom, and AI-driven markets. The company demonstrates strong business quality with 40.3% return on equity, 7.6% revenue growth, and 11.8% earnings growth year-over-year, supported by a robust $1.89 billion free cash flow and a $15 billion baโ€ฆ
Accumulation Zones
Metric ORCL VRT
Zone Low $163.69 $204.49
Zone High $185.52 $231.75
In Buy Zone? Yes No
โ† ORCL Research    VRT Research โ†’    All Research